Group One Trading’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-95,500
| Closed | -$401K | – | 8526 |
|
|
2023
Q1 | $401K | Sell |
95,500
-160,500
| -63% | -$833K | ﹤0.01% | 2973 |
|
|
2022
Q4 | $1.54M | Buy |
256,000
+70,100
| +38% | +$383K | ﹤0.01% | 2055 |
|
|
2022
Q3 | $1.08M | Sell |
185,900
-75,600
| -29% | -$471K | ﹤0.01% | 2509 |
|
|
2022
Q2 | $1.56M | Buy |
261,500
+156,500
| +149% | +$801K | ﹤0.01% | 2291 |
|
|
2022
Q1 | $490K | Sell |
105,000
-17,500
| -14% | -$52.2K | ﹤0.01% | 3841 |
|
|
2021
Q4 | $304K | Buy |
122,500
+86,700
| +242% | +$212K | ﹤0.01% | 4647 |
|
|
2021
Q3 | $106K | Sell |
35,800
-95,400
| -73% | -$260K | ﹤0.01% | 5859 |
|
|
2021
Q2 | $328K | Buy |
131,200
+123,900
| +1,697% | +$297K | ﹤0.01% | 4697 |
|
|
2021
Q1 | $21K | Buy |
7,300
+1,500
| +26% | +$4.9K | ﹤0.01% | 6754 |
|
|
2020
Q4 | $19K | Sell |
5,800
-900
| -13% | -$2.99K | ﹤0.01% | 5561 |
|
|
2020
Q3 | $14K | Buy |
6,700
+1,700
| +34% | +$2.17K | ﹤0.01% | 5308 |
|
|
2020
Q2 | $6K | Sell |
5,000
-16,000
| -76% | -$16.9K | ﹤0.01% | 5339 |
|
|
2020
Q1 | $19K | Buy |
21,000
+1,000
| +5% | +$1.15K | ﹤0.01% | 4269 |
|
|
2019
Q4 | $32K | Buy |
+20,000
| New | +$18.9K | ﹤0.01% | 4204 |
|
|
2019
Q2 | – | Sell |
-15,000
| Closed | -$15K | – | 5763 |
|
|
2019
Q1 | $15K | Buy |
+15,000
| New | +$15.8K | ﹤0.01% | 4146 |
|
|
2018
Q3 | – | Sell |
-12,400
| Closed | -$62K | – | 5991 |
|
|
2018
Q2 | $62K | Sell |
12,400
-11,400
| -48% | -$49.9K | ﹤0.01% | 3846 |
|
|
2018
Q1 | $93K | Buy |
+23,800
| New | +$83.7K | ﹤0.01% | 3296 |
|
|
2017
Q4 | – | Sell |
-800
| Closed | -$3K | – | 5632 |
|
|
2017
Q3 | $3K | Sell |
800
-6,600
| -89% | -$22K | ﹤0.01% | 4622 |
|
|
2017
Q2 | $24K | Buy |
+7,400
| New | +$28.8K | ﹤0.01% | 3885 |
|
|
2016
Q3 | – | Sell |
-500
| Closed | -$2K | – | 5339 |
|
|
2016
Q2 | $2K | Hold |
500
| – | – | ﹤0.01% | 4482 |
|
|
2016
Q1 | $3K | Sell |
500
-24,270
| -98% | -$194K | ﹤0.01% | 4353 |
|
|
2015
Q4 | $305K | Sell |
24,770
-640
| -3% | -$8.54K | ﹤0.01% | 2193 |
|
|
2015
Q3 | $371K | Sell |
25,410
-250
| -1% | -$4.32K | 0.01% | 2016 |
|
|
2015
Q2 | $500K | Sell |
25,660
-24,500
| -49% | -$473K | 0.01% | 1790 |
|
|
2015
Q1 | $908K | Buy |
50,160
+16,570
| +49% | +$373K | 0.01% | 1162 |
|
|
2014
Q4 | $793K | Sell |
33,590
-2,680
| -7% | -$62K | 0.01% | 1211 |
|
|
2014
Q3 | $878K | Buy |
36,270
+150
| +0.4% | +$3.9K | 0.01% | 1199 |
|
|
2014
Q2 | $1.01M | Buy |
36,120
+10,040
| +38% | +$302K | 0.02% | 1131 |
|
|
2014
Q1 | $887K | Sell |
26,080
-1,540
| -6% | -$52.6K | 0.01% | 1187 |
|
|
2013
Q4 | $530K | Buy |
27,620
+27,250
| +7,365% | +$496K | 0.01% | 1618 |
|
|
2013
Q3 | $6K | Buy |
+370
| New | +$4.29K | ﹤0.01% | 4732 |
|
Other funds holding CTIC
Group One Trading's CTIC Position: Q2 2023 in Review
Group One Trading sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 16,573 shares — an estimated $69.6K sold.
Group One Trading first reported a position in CTIC in Q2 2013 and held it in 24 quarters. The position peaked at $970K in Q2 2022. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.
- Group One Trading reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
- Group One Trading sold 16,573 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $69.6K.
- Group One Trading first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2013 and held it in 24 quarters.
- Group One Trading's CTI BioPharma Corp. (DE) Common Stock position peaked at $970K in Q2 2022.
- 2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.
Based on Group One Trading's 13F filing for Q2 2023, filed 9 Aug 2023.